Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Volume: 367, Issue: 19, Pages: 1783 - 1791
Published: Nov 8, 2012
Abstract
Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)–targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1. The antibody and the cytotoxic agent are conjugated by means of a stable...
Paper Details
Title
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Published Date
Nov 8, 2012
Volume
367
Issue
19
Pages
1783 - 1791
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History